SAN DIEGO–(BUSINESS WIRE)–MediPrint™ Ophthalmics Announces Acceptance and Presentation of Poster at the Upcoming GSLS in Las Vegas
Category: Business
Global Contact Lenses Industry to 2027 – Demand for Multifocal Contact Lenses on the Rise – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Contact Lenses estimated at US$11.4 Billion in the year…
Kubota Vision Initiates PBOS Prospective Study in Patients
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that on January 17…
首尔半导体对SunLike照明的近视改善效果予以证明
韩国安山–(BUSINESS WIRE)–首尔半导体对SunLike照明的近视改善效果予以证明
Europe Eyewear and Optical Retailers Database 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear and Optical Retailers in Europe” newsletter has been added to ResearchAndMarkets.com’s offering. For each country, similar rankings are provided covering all the major optical retailers. This database covers all ma…
Insights on the Ophthalmic Equipment Global Market to 2027 – Featuring Alcon, Canon Medical Systems and Diamatrix Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Equipment Market Research Report by Product, by End-user, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmic Eq…
The Worldwide AR Glasses Industry is Expected to Reach $883.4 Million by 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “AR Glasses Market – Global Industry Analysis (2017 – 2020) – Growth Trends and Market Forecast (2021 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The global AR glasses market will be valued at $883….
UnitedHealthcare Enhances Eye Care Program by Helping Reduce People’s Exposure to Blue Light
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is investing in new ways to help children and adults across the country reduce their exposure to blue light and support their overall eye health, amid ongoi…
Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced positive top-line data from a…
Worldwide Prescription Lens Industry to 2027 – Increasing Living Standards Among Young Population with the Need for Trending Sunglasses and Lens Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Prescription Lens Market Research Report by Type, by Application, by Coating, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The global pres…
Worldwide Advanced Ophthalmology Technologies Industry to 2027 – Technological Advancements in Ophthalmic Devices Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Advanced Ophthalmology Technologies Market Research Report by Type, by End-user, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The global a…
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
GENEVA–(BUSINESS WIRE)–Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
TOKYO–(BUSINESS WIRE)– #Asia–Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal Endothelial Cell Substitute from…
The Beekman Group Partners with Campus Eye to Accelerate Growth
NEW YORK–(BUSINESS WIRE)–The Beekman Group is pleased to announce that an affiliate of Beekman Investment Partners IV (“Beekman”) has formed a strategic partnership with Campus Eye Group of Hamilton, NJ and Total Eye Care (“TECC”) of Levittown, PA, c…
EyeSouth Partners Completes its 27th Affiliation Through Partnership with Clayton Eye Center
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Clayton Eye Center (“CEC”). The affiliation represents EyeSouth’s eleventh in the state of Georgia and twenty-sev…
Mojo Vision Partners With Fitness Brands to Elevate Sports and Fitness Experience and Performance via Its Smart Contact Lens
SARATOGA, Calif.–(BUSINESS WIRE)–Mojo Vision, the Invisible Computing Company, today announced strategic partnerships with leading sports and fitness brands to collaborate on next-generation user experiences that combine augmented reality, wearable t…
Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that B…
Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases
SAN DIEGO–(BUSINESS WIRE)– #genetic–Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases.
Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced completion of enrollment in P…